Apes Show Ability to Imagine in ‘Tea Party’ Experiments, and Scientists are Very Excited

43-year-old bonobo named Kanzi – Courtesy of Ape Initiative / Johns Hopkins / SWNS

Apes share the human ability to imagine and pretend, suggests new research that included a series of tea party experiments.

Scientists at Johns Hopkins University in Baltimore, Maryland, called it the first study to show the capacity for pretending is not unique to mankind.

They learned that apes can use their imagination and play pretend. One bonobo engaged with cups of imaginary juice and bowls of pretend grapes “consistently and robustly” across three experiments, challenging long-held assumptions about the abilities of animals.

The findings, published this week in the journal Science, suggest that the capacity to understand pretend objects is within the cognitive potential of, at least, an “enculturated ape”, and likely dates back six to nine million years, to our common evolutionary ancestors.

“It really is game-changing that their mental lives go beyond the here and now,” said study co-author Dr. Christopher Krupenye.

“Imagination has long been seen as a critical element of what it is to be human, but the idea that it may not be exclusive to our species is really transformative.

“Jane Goodall discovered that chimps make tools and that led to a change in the definition of what it means to be human—and this, too, really invites us to reconsider what makes us special and what mental life is out there among other creatures.”

He said that, by the age of two, human children can engage in pretend scenarios, like tea parties. Even at 15-months-old, infants show measures of surprise when they see a person “drinking” from a cup after pretending to empty it.

Credit: Getty Images For Unsplash+

There had been no previous studies of pretend behavior in non-human animals, despite several reports of animals seemingly engaging in pretending behavior from both the wild and in zoos or captivity.

For instance, in the wild, young female chimps have been observed carrying and playing with sticks, holding them like mothers would hold their infants. And a chimp in captivity seemed to drag imaginary blocks along the floor after playing with real wooden blocks.

Dr. Krupenye and co-author Amalia Bastos, a former Johns Hopkins postdoctoral fellow who is now a lecturer at the University of St. Andrews in Scotland, wondered if they could test the capacity to pretend in a controlled environment.

They created experiments similar to a child’s tea party to test Kanzi, a 43-year-old bonobo living at Ape Initiative in Iowa, is the world’s only research center and sanctuary dedicated exclusively to the study and conservation of bonobos, our closest primate relative.

Kanzi had been anecdotally reported to engage in pretense, and could respond to verbal prompts by pointing.

In each test, a researcher and Kanzi faced one another, tea party-style, across a table. In the first task there were two transparent cups on the table, both empty, alongside an empty transparent pitcher.

Kanzi – Courtesy of Ape Initiative / Johns Hopkins / SWNS

The researcher tipped the pitcher to “pour” a little pretend juice into each cup, then pretended to dump the juice out of one cup, shaking it a bit to really get it out.

The researcher then asked Kanzi: “Where’s the juice?”

The bonobo pointed to the correct cup that still contained pretend juice, even when the researcher changed the position of the cup filled with pretend juice.


In case Kanzi thought there was real juice in the cup, even if he couldn’t see it, the team ran a second experiment, during which a cup of real juice was placed alongside the cup of pretend juice.

When Kanzi was asked what he wanted, he pointed toward the real juice almost every time.

A third experiment repeated the same concept, except with grapes. A researcher pretended to sample a grape from an empty container, then placed it inside one of the two jars.

After pretending to empty one of the containers, he asked Kanzi: “Where’s the grape?”

Kanzi again indicated the location of the pretend object. The researchers said Kanzi wasn’t perfect, but he was consistently correct.

“It’s extremely striking and very exciting that the data seem to suggest that apes, in their minds, can conceive of things that are not there,” said Dr. Bastos.

“Kanzi is able to generate an idea of this pretend object and, at the same time, know it’s not real.”

The researchers now want to test whether other apes and animals can engage in pretend play or track pretend objects. They also hope to explore other facets of imagination in apes, perhaps their ability to think about the future or to think about what’s going on in the minds of others.

“Imagination is one of those things that in humans gives us a rich mental life,” said Dr. Krupenye.“And if some roots of imagination are shared with apes, that should make people question their assumption that other animals are just living robotic lifestyles constrained to the present. We should be compelled by these findings to care for these creatures with rich and beautiful minds and ensure they continue to exist.” Apes Show Ability to Imagine in ‘Tea Party’ Experiments, and Scientists are Very Excited
Read More........

Successful World First: Baby Treated with Personalized CRISPR Gene Therapy for Rare Disease is Now ‘Thriving’

Dr. Kiran Musunru (left) and Dr. Rebecca Ahrens-Nicklas (right) led the researchers who developed a personalized treatment for baby KJ – Released CHOP and Penn

CRISPR has been used to create a genetic therapy option for a child born in Pennsylvania with a rare metabolic disorder.

Unable to convert ammonia to urea, newborn KJ was in serious risk of brain or liver damage, and had to be kept on medications and an extremely restrictive diet to avoid protein metabolism.

Children’s Hospital of Philadelphia (CHOP) doctors believed they could use CRISPR to develop a treatment to correct a faulty gene in KJ’s genome that would essentially cure him.

KJ’s parents, Nicole and Kyle Muldoon, decided to place their son’s wellbeing in the hands of two pioneering genetic therapists, Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru, who crafted a bespoke treatment that has successfully corrected the genetic defect.

“Years and years of progress in gene editing and collaboration between researchers and clinicians made this moment possible, and while KJ is just one patient, we hope he is the first of many to benefit from a methodology that can be scaled to fit an individual patient’s needs,” said Rebecca Ahrens-Nicklas, MD, PhD, director of the Gene Therapy for Inherited Metabolic Disorders Frontier Program (GTIMD) at Children’s Hospital of Philadelphia.

She, along with Dr. Musunru, are members of the NIH-funded Somatic Cell Genome Editing Consortium, and have spent years developing the science of using CRISPR to create individual treatment doses for the rarest of diseases.

So far, the only FDA-approved and standardized CRISPR therapies target two diseases found in tens of thousands of patients. CRISPR is an incredibly complex tool and expensive to wield, leaving its magic beyond the reach of millions of children and adults worldwide who collectively suffer from extremely rare genetic disorders.

One such disorder is called severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, and it creates the inability to properly convert ammonia into urea to be excreted through urine. Ammonia is created in the body through protein metabolism. CPS1 is created in the liver to turn it into urea so as to avoid the toxic effects of the former.

KJ’s body cannot, so excess protein metabolism creates a buildup of ammonia in his liver that could be fatal. Nitrogen scavenging medication and a protein-deficient diet can keep a patient going until a liver transplant can be found, but at just months old, KJ’s body isn’t capable of enduring the procedure.

A news release from CHOP reports that Ahrens-Nicklas and Musunuru targeted KJ’s specific variant of CPS1 after years of work with similar disease-causing variants. Within 6 months, their team designed and manufactured a base editing therapy delivered via lipid nanoparticles to the liver in order to correct KJ’s faulty enzyme.

In late February, 2025, KJ received his first infusion of this experimental therapy, and since then has received follow-up doses in March and April 2025, the release details. In the newly published New England Journal of Medicine paper, the researchers, along with their academic and industry collaborators, describe the customized CRISPR gene editing therapy that was rigorously yet speedily developed for administration to KJ.

KJ has received 3 doses, and suffered no side effects. He’s been able to halt medication and work some protein back into his diet, though he will need careful monitoring the rest of his life.“We thought it was our responsibility to help our child, so when the doctors came to us with their idea, we put our trust in them in the hopes that it could help not just KJ but other families in our position,” his mother, Nicole, told CHOP. Successful World First: Baby Treated with Personalized CRISPR Gene Therapy for Rare Disease is Now ‘Thriving’
Read More........